Guidelines for Optimal Patient Outcomes Using Calcium Hydroxylapatite for Jawline Contour
Abstract BackgroundCalcium hydroxylapatite (CaHA(+); Radiesse(+) [Merz North America, Inc., Raleigh, NC]) is the first FDA-approved injectable filler for subdermal and/or supraperiosteal injection to improve moderate-to-severe loss of jawline contour. CaHA has been...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2023-03-01
|
| Series: | Aesthetic Surgery Journal Open Forum |
| Online Access: | https://academic.oup.com/asjopenforum/article-lookup/doi/10.1093/asjof/ojad019 |